vimarsana.com

Latest Breaking News On - Schering plough research - Page 2 : vimarsana.com

Nuvalent Appoints Michael L. Meyers, MD, PhD, to Board of Directors

/PRNewswire/ Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically.

New-york
United-states
Memorial-sloan-kettering-cancer-center
Cambridge
Cambridgeshire
United-kingdom
Michaell-meyers
James-porter
Linkedin
Nuvalent-inc
Twitter
Schering

Nuvalent Inc (NUVL) Appoints Michael L. Meyers to its Board

Nuvalent Inc (NUVL) Appoints Michael L. Meyers to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Memorial-sloan-kettering-cancer-center
Michaell-meyers
James-porter
Nuvalent-inc
Us-oncology-medical-affairs
Albert-einstein-college-of-medicine
Aventis-pharmaceuticals-inc
Schering
Nasdaq
Plough-research-institute

Biotheryx Announces Appointment of Tracy Lawhon as Chief Development Officer

/PRNewswire/ Biotheryx, Inc., a clinical stage company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs).

Philippe-drouet
Tracy-lawhon
Indiana-university
Adastra-pharmaceuticals-inc
Indiana-university-school-of-law
Schering
Plough-research-institute
Novartis
Clinical-operations-at-valo-health-inc
Cabrellis-pharmaceuticals
Prnewswire-biotheryx-inc
Strategic-development

Teva appoints Eric Hughes as head of R&D and Chief Medical Officer

Dr Eric Hughes will join Teva as Executive Vice President, Global R&D and Chief Medical Officer in August 2022.

Boston
Massachusetts
United-states
Yale-school
New-jersey
Parsippany
Hafrun-fridriksdottir
Derica-hughes
Eric-hughes
Brian-hughes
Bristol-myers-squibb
Vertex-pharmaceuticals

Teva Pharmaceutical names new member to exec team

Teva Pharmaceutical appointed Dr. Eric Hughes as executive vice president, global R&D and chief medical officer, effective Aug. 1.

Hafrun-fridriksdottir
Eric-hughes
Bristol-myers-squibb
Vertex-pharmaceuticals
Yale-school-of-medicine
Merck-research-laboratories
Schering
Plough-research-institute
Bristol-myers-squibb-co
Cardiology-exploratory-clinical-translational-research
Hepatology-dermatology-global-development-unit-at-novartis
Teva-pharmaceutical

vimarsana © 2020. All Rights Reserved.